Clinical trial
Canadian Health Economics, Health Outcome, and Effectiveness Comparison of Treatment of the Frontal Sinus Ostium and Recess and Other Sinuses With Functional Endoscopic Sinus Surgery (FESS) or Balloon Sinuplasty in Patients With Chronic Sinusitis (CRS)
NCT01455948 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Canadian Health Economics, Health Outcome, and Effectiveness Comparison of Treatment of the Frontal Sinus Ostium and Recess and Other Sinuses With Functional Endoscopic Sinus Surgery (FESS) or Balloon Sinuplasty in Patients With Chronic Sinusitis (CRS)
- Lead sponsor
- Integra LifeSciences Corporation
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 29, 2012
- Completion date
- November 30, 2012
- Enrollment
- 25 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
chronic rhinosinusitis